Commonly prepared as a sublingual troche, this formulation combines L-arginine (a nitric oxide precursor), oxytocin (a neuropeptide hormone), sildenafil (a PDE5 inhibitor), and PT-141/bremelanotide (a melanocortin receptor agonist). Together, these ingredients aim to help support sexual arousal and performance by pairing vasodilatory and central nervous system pathways. Individual response to combination sexual wellness formulations can vary.

Download a compounding order form for this medication with dose options and packaging choices.